BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

658 related articles for article (PubMed ID: 17630117)

  • 1. Histopathology of endometrial hyperplasia and endometrial carcinoma: an update.
    Horn LC; Meinel A; Handzel R; Einenkel J
    Ann Diagn Pathol; 2007 Aug; 11(4):297-311. PubMed ID: 17630117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular carcinogenesis of endometrial cancer.
    Liu FS
    Taiwan J Obstet Gynecol; 2007 Mar; 46(1):26-32. PubMed ID: 17389185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathology of endometrial hyperplasia and endometrial carcinoma. An update by Dr LC Horn et al in Annals of Diagnostic Pathology 2007;11:297-311.
    Zheng W; Chambers SK
    Ann Diagn Pathol; 2008 Jun; 12(3):231-2; author reply 232-3. PubMed ID: 18486902
    [No Abstract]   [Full Text] [Related]  

  • 4. [Precancerous lesion of the endometrium and endometrial morphology in patients with tamoxifen therapy].
    Schmidt D; Horn LC
    Zentralbl Gynakol; 2002 Jan; 124(1):3-9. PubMed ID: 11873307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Theories of endometrial carcinogenesis: a multidisciplinary approach.
    Sherman ME
    Mod Pathol; 2000 Mar; 13(3):295-308. PubMed ID: 10757340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer.
    Amant F; Cadron I; Fuso L; Berteloot P; de Jonge E; Jacomen G; Van Robaeys J; Neven P; Moerman P; Vergote I
    Gynecol Oncol; 2005 Aug; 98(2):274-80. PubMed ID: 15972232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Morphologic endometrium changes with tamoxifen].
    Dallenbach-Hellweg G; Hahn U; Schmidt D
    Zentralbl Gynakol; 1996; 118(6):365-9. PubMed ID: 8768015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dualistic model for endometrial carcinogenesis based on immunohistochemical and molecular genetic analyses.
    Lax SF; Kurman RJ
    Verh Dtsch Ges Pathol; 1997; 81():228-32. PubMed ID: 9474874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly(ADP-ribose) polymerase (PARP) and DNA-fragmentation factor (DFF45): expression and correlation in normal, hyperplastic and neoplastic endometrial tissues.
    Brustmann H
    Pathol Res Pract; 2007; 203(2):65-72. PubMed ID: 17258405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Endometrial carcinoma and precursor lesions].
    Djordjević B; Stanojević Z
    Srp Arh Celok Lek; 2007; 135(3-4):230-4. PubMed ID: 17642468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dualistic model of molecular pathogenesis in endometrial carcinoma].
    Lax SF
    Zentralbl Gynakol; 2002 Jan; 124(1):10-6. PubMed ID: 11873308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic analysis of 187 high-grade endometrial carcinomas of different histologic subtypes: similar outcomes belie distinctive biologic differences.
    Soslow RA; Bissonnette JP; Wilton A; Ferguson SE; Alektiar KM; Duska LR; Oliva E
    Am J Surg Pathol; 2007 Jul; 31(7):979-87. PubMed ID: 17592263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrial intraepithelial neoplasia (EIN): will it bring order to chaos? The Endometrial Collaborative Group.
    Mutter GL
    Gynecol Oncol; 2000 Mar; 76(3):287-90. PubMed ID: 10684697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression.
    Lax SF; Pizer ES; Ronnett BM; Kurman RJ
    Hum Pathol; 1998 Jun; 29(6):551-8. PubMed ID: 9635673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression pattern of osteopontin in endometrial carcinoma: correlation with expression of the adhesion molecule CEACAM1.
    Briese J; Schulte HM; Bamberger CM; Löning T; Bamberger AM
    Int J Gynecol Pathol; 2006 Apr; 25(2):161-9. PubMed ID: 16633066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of histopathological features of endometrioid uterine carcinomas and epidemiologic risk factors.
    Sturgeon SR; Sherman ME; Kurman RJ; Berman ML; Mortel R; Twiggs LB; Barrett RJ; Wilbanks GD; Brinton LA
    Cancer Epidemiol Biomarkers Prev; 1998 Mar; 7(3):231-5. PubMed ID: 9521439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New features in the 2014 WHO classification of uterine neoplasms].
    Lax SF
    Pathologe; 2016 Nov; 37(6):500-511. PubMed ID: 27738815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precursors of endometrial clear cell carcinoma.
    Fadare O; Liang SX; Ulukus EC; Chambers SK; Zheng W
    Am J Surg Pathol; 2006 Dec; 30(12):1519-30. PubMed ID: 17122507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometrial carcinomas: a review emphasizing overlapping and distinctive morphological and immunohistochemical features.
    Bartosch C; Manuel Lopes J; Oliva E
    Adv Anat Pathol; 2011 Nov; 18(6):415-37. PubMed ID: 21993268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathology of the endometrium in breast cancer patients treated with tamoxifen (nolvadex)].
    Ivanova V; Karaivanov M; Marinov E; Gorchev G; Velkova A; Khristova P
    Akush Ginekol (Sofiia); 2003; 42(5):3-8. PubMed ID: 14682005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.